Executives Across Biotech, Software and Media Sold Over $80 Million in Stock in a Single Stretch

Regulatory filings compiled from recent disclosures show a wide insider-selling pattern that cuts across industries rather than sitting in one sector. Illumina director Keith Meister sold $57.2 million in stock, the largest single transaction in the batch. Krystal Biotech's president of R&D, Suma Krishnan, sold $8.98 million, while NMI Holdings CEO Adam Pollitzer sold $7.75 million and Warner Bros. Discovery director Lowe reported a $5.67 million sale. Smaller but still notable sales came from CrowdStrike CEO George Kurtz, who sold $4.16 million in shares, Salesforce director Craig Conway, who sold $1.17 million, StubHub president Nayaab Islam, who sold $899,000, and Evolus CEO David Moatazedi, who sold $950,018. Enovis was the exception: its CAO and CEO both bought stock, purchasing $149,970 and $249,620 respectively, suggesting the selling wave is not universal. Insider sales alone rarely predict near-term price moves, since many are pre-scheduled under 10b5-1 trading plans disclosed well in advance. What is unresolved from the available filings is whether these particular sales were scheduled or discretionary, and whether the volume represents a genuine shift in executive sentiment toward valuations or simple portfolio diversification after strong run-ups in these names.